Skip to content

Maryam Ardalan

3 papers in the library · 38 citations · publishing 2016-2026

Papers

Sort Most recent Most cited

Psilocybin elicits a conserved glucocorticoid-responsive gene signature across five 5-HT2A receptor-rich brain regions in rat.

Acta Neuropsychiatrica April 10, 2026 Ashkan Veysi, Daniela Atanasovski, Maryam Ardalan et al.

Psychedelics such as psilocybin are known for their hallucinogenic properties and have also been reported to produce long-lasting therapeutic effects in depression and possibly also other psychiatric disorders. Several lines of evidence suggest that psilocybin exerts its effects through activation of 5-HT2A receptors located postsynaptically to serotonergic neurons, for example, in the frontal...

S-Ketamine Rapidly Reverses Synaptic and Vascular Deficits of Hippocampus in Genetic Animal Model of Depression

The International Journal of Neuropsychopharmacology November 2, 2016 Maryam Ardalan, Gregers Wegener, Ali H. Rafati et al. 38 citations

Background: The neurovascular plasticity of hippocampus is an important theory underlying major depression. Ketamine as a novel glutamatergic antidepressant drug can induce a rapid antidepressant effect within hours. In a mechanistic proof of this concept, we examined whether ketamine leads to an increase in synaptogenesis and vascularization within 24 hours after a single injection in a...

Neurovascular plasticity of the hippocampus one week after a single dose of ketamine in genetic rat model of depression.

Hippocampus November 2016 Maryam Ardalan, Gregers Wegener, Benedetta Polsinelli et al.

Glutamatergic system and the structural plasticity hypothesis are principal components for rapid and sustained antidepressant effects of novel antidepressant therapeutics. This study represents the first investigation of the structural plasticity of the hippocampus as one of the main contributed mechanisms to the sustained anti-depressive effect of ketamine. Flinders Sensitive Line (FSL) and...